Back to Search
Start Over
Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units
- Source :
- Alimentary Pharmacology & Therapeutics (Suppl), Alimentary Pharmacology & Therapeutics (Suppl), 2017, 46 (11-12), pp.1070-1076. ⟨10.1111/apt.14367⟩
- Publication Year :
- 2017
- Publisher :
- HAL CCSD, 2017.
-
Abstract
- IF 7.286; International audience; BACKGROUND:The outcome of cholangiopathy developing in intensive care unit (ICU) is not known in patients surviving their ICU stay.AIM:To perform a survey in liver units, in order to clarify the course of cholangiopathy after surviving ICU stay.METHODS:The files of the liver units affiliated to the French network for vascular liver disease were screened for cases of ICU cholangiopathy developing in patients with normal liver function tests on ICU admission, and no prior history of liver disease.RESULTS:Between 2005 and 2015, 16 cases were retrieved. Extensive burns were the cause for admission to ICU in 11 patients. Serum alkaline phosphatase levels increased from day 11 (2-46) to a peak of 15 (4-32) × ULN on day 81 (12-511). Magnetic resonance cholangiography showed irregularities or frank stenosis of the intrahepatic ducts, and proximal extrahepatic ducts contrasting with a normal aspect of the distal common bile duct. Follow-up duration was 20.6 (4.7-71.8) months. Three patients were lost to follow-up; 2 patients died from liver failure and no patient was transplanted. One patient had worsening strictures of the intrahepatic bile ducts with jaundice. Nine patients had persistent but minor strictures of the intrahepatic bile ducts on MR cholangiography, and persistent cholestasis without jaundice. One patient had normal liver function tests.CONCLUSIONS:In patients surviving their ICU stay, ICU cholangiopathy is not uniformly fatal in the short term or clinically symptomatic in the medium term. Preservation of the distal common bile duct appears to be a finding differentiating ICU cholangiopathy from other diffuse cholangiopathies.
- Subjects :
- Male
Gastroenterology
Distal Common Bile Duct
Liver disease
0302 clinical medicine
Cholangiography
Liver Function Tests
Surveys and Questionnaires
MESH: Liver Function Tests
Pharmacology (medical)
MESH: Cholangiography
ComputingMilieux_MISCELLANEOUS
Aged, 80 and over
MESH: Aged
MESH: Middle Aged
medicine.diagnostic_test
Liver Diseases
MESH: Aged 80 and over
Middle Aged
Jaundice
3. Good health
Intensive Care Units
MESH: Young Adult
030220 oncology & carcinogenesis
MESH: Critical Illness
Female
030211 gastroenterology & hepatology
medicine.symptom
Adult
medicine.medical_specialty
MESH: Liver Diseases
Adolescent
Critical Care
Critical Illness
Intrahepatic bile ducts
Bile Duct Diseases
Young Adult
03 medical and health sciences
Cholestasis
MESH: Critical Care
Internal medicine
Intensive care
medicine
Humans
Secondary Sclerosing Cholangitis
MESH: Surveys and Questionnaires
Aged
Retrospective Studies
MESH: Adolescent
MESH: Humans
Hepatology
business.industry
MESH: Adult
MESH: Retrospective Studies
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
medicine.disease
MESH: Male
Bile Ducts, Intrahepatic
MESH: Intensive Care Units
MESH: Bile Duct Diseases
MESH: Bile Ducts
business
Liver function tests
MESH: Female
Subjects
Details
- Language :
- English
- ISSN :
- 09530673 and 13652036
- Database :
- OpenAIRE
- Journal :
- Alimentary Pharmacology & Therapeutics (Suppl), Alimentary Pharmacology & Therapeutics (Suppl), 2017, 46 (11-12), pp.1070-1076. ⟨10.1111/apt.14367⟩
- Accession number :
- edsair.doi.dedup.....4df5758f32fb77dd94a7093512e591e5
- Full Text :
- https://doi.org/10.1111/apt.14367⟩